Overdiagnosis in melanoma is a nuanced and evolutionary issue. It may appear to be an epidemic from an epidemiological point of view; however, it is important to appreciate all perspectives. We consider overdiagnosis a necessary challenge—which drives clinicians to improve diagnostic accuracy and reduce overtreatment—pathologists to recalibrate histopathological thresholds and reduce overcalling—and researchers to develop markers of biological activity for melanoma. In this article, we present our clinical perspective on the current burden of melanoma overdiagnosis and its future value for progress in the field of melanoma.

Source:

J. Sheerin, H. Collgros, A. Chamberlain, et al., “ A Clinical Perspective on Melanoma Overdiagnosis,” Australasian Journal of Dermatology (2025): 1–8

https://onlinelibrary.wiley.com/doi/10.1111/ajd.14581